Binance, Bybit, and Bitget halted their tokenized SpaceX IPO campaigns after failing to secure enough shares through their equity partner xStocks. Despite strong retail demand, xStocks could not obtain sufficient allocations from the traditional IPO process, leading to full refunds and compensation offers to investors. This highlights challenges in linking blockchain-based tokenized securities with limited Wall Street IPO shares. The incident underscores current limits of on-chain finance but does not diminish interest in tokenized stocks as the market evolves.
Crinetics Pharmaceuticals presented positive Phase 2 trial results for atumelnant, an oral ACTH receptor antagonist, showing it effectively lowers androgen levels and allows reduction of glucocorticoid doses in adults with classic congenital adrenal ...
NYDIG revisited its Bitcoin Cycles Narratives Framework, confirming Bitcoin is still in the contraction phase after a 53% price drop from its 2025 peak. Key demand drivers like spot Bitcoin ETF inflows and corporate treasury buying have weakened, rem...
In Q1 2026, Cardano's ADA token price dropped 27.4% to $0.24, reflecting short-term market weakness amid broader ecosystem declines like a 23.5% drop in DeFi value locked and 28.1% fewer active addresses. However, Cardano advanced significantly in bu...
US spot Bitcoin ETFs saw net inflows exceed $100 billion in 2025, led by institutional investors like BlackRock and Morgan Stanley. This surge is fueled by clearer SEC regulations, improved custody solutions, and macroeconomic pressures pushing insti...
Zymeworks Inc. presented new Phase 1 data for ZW191, an antibody-drug conjugate targeting folate receptor alpha, showing promising anti-tumor activity in platinum-resistant ovarian cancer patients regardless of receptor expression levels. The confirm...
